| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/08/2007 | US20070032445 Antisense IAP nucleobase oligomers and uses thereof |
| 02/08/2007 | US20070032443 Therapy for Alzheimer's disease |
| 02/08/2007 | US20070032440 Oligonucleotides directed against a survivin gene and use thereof |
| 02/08/2007 | US20070032438 Pharmaceutical compositions containing taxanes and methods for preparing the pharmaceutical compositions |
| 02/08/2007 | US20070032437 Iap binding compounds |
| 02/08/2007 | US20070032436 Pharmaceutical formulations |
| 02/08/2007 | US20070032435 Pharmaceutical formulations |
| 02/08/2007 | US20070032433 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 02/08/2007 | US20070032427 Methods and compositions for preserving the viability of photoreceptor cells |
| 02/08/2007 | US20070032426 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 02/08/2007 | US20070032425 Compositions for diabetes treatment and prophylaxis |
| 02/08/2007 | US20070032422 Methods, compositions and articles of manufacture for contributing to the treatment of cancers |
| 02/08/2007 | US20070032418 Small-molecule inhibitors of angiogenin and rnases and in vivo and in vitro methods of using same |
| 02/08/2007 | US20070032409 Bradykinin receptor antagonists and uses thereof |
| 02/08/2007 | US20070032407 Use treating hepatitis C infection optionally with other viricides such as interferons or ribavirin; low toxicity to the host; use of cytosine-based nucleotides or nucleosides having a 2'-trifluoromethyl-ribose moiety which forms a 5'-phosphate or hydroxy moiety in vivo |
| 02/08/2007 | US20070032406 Identification of novel nogo-receptors and methods related thereto |
| 02/08/2007 | US20070032405 Branched water-soluble polymers and their conjugates |
| 02/08/2007 | US20070032404 Methods for treating diabetes and related disorders using pde10a inhibitors |
| 02/08/2007 | US20070031965 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism |
| 02/08/2007 | US20070031945 High mannose proteins and methods of making high mannose proteins |
| 02/08/2007 | US20070031907 Anaplastic lymphoma kinase assay, reagents and compositions thereof |
| 02/08/2007 | US20070031904 Mammalian IAP gene family, primers, probes and detection methods |
| 02/08/2007 | US20070031903 Mammalian IAP gene family, primers, probes and detection methods |
| 02/08/2007 | US20070031898 Contacting a first portion of a peripheral blood sample that contains mononuclear cells with a fluorescence-labeled immunostimulant polysaccharide such as a beta-glucan or lentinan and measuring its fluorescent intensity to determine cell bonding; and comparing the intensity to that of a reference |
| 02/08/2007 | US20070031887 Aqueous-based pharmaceutical composition |
| 02/08/2007 | US20070031882 Methods and compositions for treating AIDS and HIV-related disorders using 1414, 1481,1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784 or 2045 molecules |
| 02/08/2007 | US20070031874 Modulating SOS response induction by antimicrobial agents |
| 02/08/2007 | US20070031860 G-protein coupled receptor and uses therefor |
| 02/08/2007 | US20070031838 Method |
| 02/08/2007 | US20070031821 Screening molecules with anti-prion activity: kits, methods and screened molecules |
| 02/08/2007 | US20070031570 Hydrothermically processed compositions containing phytosterols |
| 02/08/2007 | US20070031526 Topical Deodorant Compositions Based on Hydroxycitric Acid |
| 02/08/2007 | US20070031523 purified plant extract for treating menopausal-syndrome; no side effect; ameliorating ovary function and regulating estrogen and progestogen, prevent many diseases due to imbalance of estrogen and progestrogen; for patients which need to use estrogen but with contraindication of hormone |
| 02/08/2007 | US20070031521 Synergistic composition for the treatment of diabetes mellitus |
| 02/08/2007 | US20070031520 Method of using ajoene as alcohol dehydrogenase inhibitor, composition for removing hangover comprising ajoene and method of preparing the same |
| 02/08/2007 | US20070031518 Cytokine modulators and related methods of use |
| 02/08/2007 | US20070031516 Composition for the prevention and treatment of cellulitis |
| 02/08/2007 | US20070031514 Use of isoindolinone derivatives as insecticides |
| 02/08/2007 | US20070031513 Carbostyril derivatives and mood stabilizers for treating mood disorders |
| 02/08/2007 | US20070031511 Method of treatment |
| 02/08/2007 | US20070031510 Pharmaceutical combination preparation containing glycyrrhizine, zinc, and a compound comprising a thiol group or a group that is metabolized thereto |
| 02/08/2007 | US20070031502 Pharmaceutical composition for the treatment of acute disorders |
| 02/08/2007 | US20070031500 Long-acting solid formulation comprising triptorelin acetate |
| 02/08/2007 | US20070031498 Gel composition for cellular adhesion inhibition |
| 02/08/2007 | US20070031497 Gastric acid secretion inhibiting composition |
| 02/08/2007 | US20070031493 Pharmaceutical compositions |
| 02/08/2007 | US20070031490 Effervescent powders for inhalation |
| 02/08/2007 | US20070031489 administering sub-analgesic dosage of a mu -opioid agonist selected from morphine, fentanyl, sufentanil, alfentanil, oxymorphone and hydromorphone, or salt, and a sub-analgesic dosage of oxycodone, a kappa 2-opioid agonist to prevent sleep apnea while treating pain |
| 02/08/2007 | US20070031487 Vitamin A, vitamin B1, vitamin B2, vitamin B6, vitamin B12, folic acid, vitamin D3, vitamin C, vitamin E, niacin, copper, magnesium, zinc, and iron |
| 02/08/2007 | US20070031486 Nutritional supplement for use under physiologically stressful conditions |
| 02/08/2007 | US20070031485 Pharmaceutical composition having a cationic excipient |
| 02/08/2007 | US20070031484 Immunoliposomes that optimize internationalization into target cells |
| 02/08/2007 | US20070031483 Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin |
| 02/08/2007 | US20070031482 PDT treatment method for cellulites and cosmetic use |
| 02/08/2007 | US20070031481 Phospolipid derivative |
| 02/08/2007 | US20070031480 Enhanced delivery of sphingolipids |
| 02/08/2007 | US20070031479 Bioadhesive gel based on hydroxyethycellulose |
| 02/08/2007 | US20070031476 Agent and method for treating cancer comprising strontium, amino acid(s) and mineral agent(s) |
| 02/08/2007 | US20070031475 Nutritional composition with unsaturated fatty acids and trace elements |
| 02/08/2007 | US20070031473 Drug delivery system and method |
| 02/08/2007 | US20070031472 Steroid-containing sustained release intraocular implants and related methods |
| 02/08/2007 | US20070031469 Dyed polymethyl methacrylate bone cement and process for its production |
| 02/08/2007 | US20070031461 An antimicrobial composition for topical application and a method thereof |
| 02/08/2007 | US20070031460 micelles; cyclosporin A solubilized via fatty acid and/or fatty alcohol |
| 02/08/2007 | US20070031459 Oral suspension of prednisolone acetate |
| 02/08/2007 | US20070031447 Method of isolating biologically active fraction containing clinically acceptable native S-lipopolysaccharides obtained from bacteria producing endotoxic lipopolysaccharides |
| 02/08/2007 | US20070031443 Methods for treating or preventing skin disorders using CD2-binding agents |
| 02/08/2007 | US20070031437 Compositions and methods for modulating vascular development |
| 02/08/2007 | US20070031415 Regulation of interaction between rapl and rap1 |
| 02/08/2007 | US20070031413 Treatment with anti-vegf antibodies |
| 02/08/2007 | US20070031400 Dichloroacetate in combination with clinically high levels of cardioprotective or hemodynamic drugs |
| 02/08/2007 | US20070031398 One of several enzyme-containing compounds, dietetic food products and drugs produced from and the use therefor for medical purpose |
| 02/08/2007 | US20070031394 Method of treating neurological disorders |
| 02/08/2007 | US20070031375 IL-16 antagonist peptides and DNA encoding the peptides |
| 02/08/2007 | US20070031374 Treating cell proliferative disorders via administration of mixture comprising interleukin-21 and anti-cancer monoclonal antibody |
| 02/08/2007 | US20070031372 Vaccine immunotherapy for immune suppressed patients |
| 02/08/2007 | US20070031371 Method for Preparing Branched Functionalized Polymers Using Branched Polyol Cores |
| 02/08/2007 | US20070031370 Amine N-oxide based surfactants |
| 02/08/2007 | US20070031361 Cosmetic, pharmaceutical and dermatological preparations comprising homopolymer and/or copolymer waxes of the monomers ethylene and/or propylene |
| 02/08/2007 | US20070031349 Rapidly absorbing oral formulations of PDE 5 inhibitors |
| 02/08/2007 | US20070031347 Powdered Medicaments Containing A Tiotropium Salt and Salmeterol Xinafoate |
| 02/08/2007 | US20070031344 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
| 02/08/2007 | US20070031342 Sustained release microparticles for pulmonary delivery |
| 02/08/2007 | US20070031341 Methods of delivering therapeutics to the brain |
| 02/08/2007 | US20070031338 Embolized cryoablation for treatment of tumors |
| 02/08/2007 | US20070031335 Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| 02/08/2007 | US20070031332 Angiogenic agents from plant extracts, gallic acid, and derivatives |
| 02/08/2007 | US20070031331 Treatment of Disorders |
| 02/08/2007 | US20070029528 Compositions and methods for facilitating reaction at room temperature |
| 02/08/2007 | DE202006017031U1 Cosmetic or dermatological preparation, useful to treat e.g. skin aging, comprises e.g. vitamin-A, phytosterol, vitamin-E, urea, caprylic/capric triglyceride, lipid, thickener, emulsifier, polymer, perfume, preservatives and water |
| 02/08/2007 | DE19930177B4 Intermolekular assoziierende Verbindungen und deren Verwendung Inter-molecular associative compounds and their use |
| 02/08/2007 | DE19858005B4 Synthetisches Nucleinsäure-Partikel Synthetic nucleic acid particles |
| 02/08/2007 | DE10260882B4 Dosieraerosole mit Sojalecithin als oberflächenaktiver Substanz und dessen Verwendung MDIs containing soy lecithin as a surfactant and its use |
| 02/08/2007 | DE102005036655A1 Behandlung von Tumoren mit IKK-ß Inhibitoren Treatment of tumors with IKK-ß inhibitors |
| 02/08/2007 | DE102005036542A1 CTL-Prodrug CTL prodrug |
| 02/08/2007 | DE102005036216A1 Use of quinazoline derivatives e.g. 4-((3-chloro-4-fluoro-phenyl)amin o)-6-(1-methanesulfonyl-piperidin-4-yloxy)-7-methoxy-quinazoline, which are tyrosine kinase inhibitors, to prevent or treat symptoms of e.g. chronic rhinosinusitis |
| 02/08/2007 | DE102005035891A1 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel 8- (3-amino-piperidin-1-yl) -xanthines, their preparation and their use as medicaments |
| 02/08/2007 | DE102005035741A1 Quadratsäurederivate Squaric acid derivatives |
| 02/08/2007 | DE102005035575A1 New heteroaryl derivatives are phosphodiesterase-4 enzyme inhibitors useful for the treatment of e.g. respiratory or gastrointestinal complaints or diseases, depression, Alzheimer's disease and Parkinson's disease |
| 02/08/2007 | DE102004032440B4 Verwendung von trisubstituierten Benzopyranonen Use of trisubstituted Benzopyranonen |